Literature DB >> 22177185

Gynecologic care for breast cancer survivors: assisting in the transition to wellness.

Ritu Salani1, Barbara L Andersen.   

Abstract

Currently, there are >2 million survivors of breast cancer in the United States. Two years after cancer treatment, patients may transition to primary care providers and/or gynecologists. Many of these survivors may have difficulties with menopausal symptoms. If they do not know already, some of these women may want or need risk assessment for hereditary- or treatment-induced second cancers. At least 20% will also have significant psychologic, sexual, and/or relationship difficulties that require attention. All of the women will need assistance to learn and follow recommendations for surveillance, detecting recurrence, and promoting wellness. Thus, gynecologists play a critical role in helping these patients in their health care transitions. To assist the gynecologists, we have reviewed the evaluation and management of common sequelae of breast cancer diagnoses and treatments.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22177185      PMCID: PMC3752900          DOI: 10.1016/j.ajog.2011.10.858

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  96 in total

1.  Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.

Authors:  Janet S Carpenter; Anna Maria Storniolo; Shelley Johns; Patrick O Monahan; Faouzi Azzouz; Julie L Elam; Cynthia S Johnson; Richard C Shelton
Journal:  Oncologist       Date:  2007-01

2.  Marital stability after breast cancer.

Authors:  M Dorval; E Maunsell; J Taylor-Brown; M Kilpatrick
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

Review 3.  Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.

Authors:  G Bachmann
Journal:  J Reprod Med       Date:  1998-11       Impact factor: 0.142

4.  Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention.

Authors:  Brittany M Brothers; Hae-Chung Yang; Daniel R Strunk; Barbara L Andersen
Journal:  J Consult Clin Psychol       Date:  2011-04

5.  Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.

Authors:  L E Hann; C S Giess; A M Bach; Y Tao; H J Baum; R R Barakat
Journal:  AJR Am J Roentgenol       Date:  1997-03       Impact factor: 3.959

6.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

Review 7.  The economic burden of depression and the cost-effectiveness of treatment.

Authors:  Philip S Wang; Gregory Simon; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

8.  Quality of life of cancer patients receiving inpatient and home-based palliative care.

Authors:  Louise Peters; Ken Sellick
Journal:  J Adv Nurs       Date:  2006-03       Impact factor: 3.187

9.  Quality of non-breast cancer health maintenance among elderly breast cancer survivors.

Authors:  Craig C Earle; Harold J Burstein; Eric P Winer; Jane C Weeks
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

Authors:  Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Gladys L Giron; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.